| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 62.589 | 54.268 | 67.452 | 15.271 | 14.523 | 8.384 | 10.131 | 5.668 | 8.592 | 4.222 |
| Total Income - EUR | 62.589 | 54.287 | 67.588 | 15.278 | 14.737 | 10.852 | 17.242 | 5.668 | 24.342 | 4.331 |
| Total Expenses - EUR | 20.317 | 18.380 | 19.918 | 26.018 | 24.226 | 16.931 | 21.660 | 14.416 | 23.980 | 20.312 |
| Gross Profit/Loss - EUR | 42.272 | 35.906 | 47.671 | -10.741 | -9.489 | -6.079 | -4.419 | -8.748 | 362 | -15.982 |
| Net Profit/Loss - EUR | 40.394 | 34.278 | 45.644 | -11.199 | -9.925 | -6.360 | -4.728 | -8.927 | 232 | -15.982 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Kardioline S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 5.249 | 742 | 33.432 | 23.660 | 14.220 | 5.140 | 0 | 625 | 324 | 49 |
| Current Assets | 186.237 | 137.607 | 152.123 | 149.471 | 146.265 | 146.912 | 145.244 | 95.878 | 92.940 | 88.989 |
| Inventories | 876 | 867 | 853 | 837 | 821 | 805 | 787 | 0 | 0 | 0 |
| Receivables | 11.083 | 14.159 | 31.201 | 30.876 | 33.865 | 33.884 | 35.189 | 33.585 | 34.015 | 34.567 |
| Cash | 129.284 | 78.045 | 76.287 | 74.780 | 69.433 | 70.876 | 68.838 | 21.738 | 18.492 | 14.215 |
| Shareholders Funds | 95.158 | 34.706 | 79.763 | 67.100 | 55.876 | 48.457 | 42.654 | -8.830 | -8.571 | -24.505 |
| Social Capital | 90 | 89 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 96.328 | 103.643 | 106.342 | 106.571 | 104.609 | 103.639 | 102.590 | 105.333 | 101.835 | 113.543 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Kardioline S.r.l.